Government Briefs

When Price Is No Object Once the Department of Energy selected Texas as the preferred site for the Superconducting Supercollider, it wanted everybody to know exactly how it had gone about assessing the environmental aspects of its big decision. The resulting document, in four volumes, weighed 26 pounds; DOE sent out 17,000 copies, at a cost of $1.4 million. That extravagant first-class mailing piqued the interest of Congress, especially members from some of The seven states that had lost out t

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Once the Department of Energy selected Texas as the preferred site for the Superconducting Supercollider, it wanted everybody to know exactly how it had gone about assessing the environmental aspects of its big decision. The resulting document, in four volumes, weighed 26 pounds; DOE sent out 17,000 copies, at a cost of $1.4 million. That extravagant first-class mailing piqued the interest of Congress, especially members from some of The seven states that had lost out to Texas, and led to a request for the General Accounting Office to investigate the matter. GAO’s conclusion is that DOE’s overriding concern was strict adherence to a federal law that requires an agency to convey its decisions to anyone expressing a view about the selection process, no matter how minor it may be. “Saving money was not a consideration,” says the GAO report, which notes that DOE could have saved $217,000 simply by using ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies